CYTK compared with ASND: revenue, margins and what each company keeps, and the suppliers and customers both name

CYTKCytokinetics Inc

Mkt capRevenueRevenue

ASNDAscendis Pharma A/S

Mkt capRevenueRevenue

Compare

CYTKCytokinetics Inc

ASNDAscendis Pharma A/S

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only CYTK 6

AMGNAmgencustomer

KRCKilroy Realtysupplier

SNYSanoficustomer

—Royalty Pharma Investments 2019 ICAVunlistedsupplier

2 more · CYTK chain ›

Shared 0

No shared counterparties.

Only ASND 3

NVONovo Nordisk A/Scustomer

—Teijinunlistedcustomer

—VISEN Pharmaceuticalsunlistedcustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

CYTKCytokinetics Inc

62.99· pre 63.15· delayed

Mkt cap$8.8BRevenue$29MQ2 FY26Revenue$88MFY25

ASNDAscendis Pharma A/S

252.96· pre 251.31· delayed

Pre-marketOct 30 '26delayed

Mkt cap$15.6BRevenue—Revenue—

Compare

Pre-marketOct 30 '26delayed

CYTKCytokinetics Inc

ASNDAscendis Pharma A/S

62.99pre 63.15delayed

Price

252.96pre 251.31delayed

$8.8B

Mkt cap

$15.6B

Q2 FY26$29M

Revenue

—

FY25$88M

Revenue

—

CYTK62.99vsASND252.96Pre-marketOct 30 '26delayed